James Treace - Mar 30, 2023 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Director
Signature: /s/ Lisa Taylor as Attorney-in-fact for James T. Treace
Stock symbol: TMCI
Transactions as of: Mar 30, 2023
Transactions value $: -$1,293,170
Form type: 4
Date filed: 3/31/2023, 09:00 PM
Previous filing: Mar 2, 2023
Next filing: May 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Sale	-$1.29M	-50K	-5.2%	$25.86	911K	Mar 30, 2023	Direct	F1, F2
holding	TMCI	Common Stock						556K	Mar 30, 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5100 to $26.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5100 to $26.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.